ALPHA IVF GROUP BERHAD
KLSE (MYR): ALPHA (0303)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.315
Today's Change
0.00 (0.00%)
Day's Change
0.315 - 0.32
Trading Volume
1,509,300
Financial
Market Cap
1,534 Million
NOSH
4,871 Million
Latest Quarter
30-Nov-2024 [#2]
Announcement Date
21-Jan-2025
Next Quarter
28-Feb-2025
Est. Ann. Date
21-Apr-2025
Est. Ann. Due Date
29-Apr-2025
QoQ | YoY
5.00% | 23.63%
Revenue | NP to SH
173,687.000 | 57,078.000
RPS | P/RPS
3.57 Cent | 8.83
EPS | P/E | EY
1.17 Cent | 26.88 | 3.72%
DPS | DY | Payout %
0.90 Cent | 2.86% | 76.91%
NAPS | P/NAPS
0.04 | 7.88
QoQ | YoY
5.33% | 367.32%
NP Margin | ROE
33.57% | 29.30%
F.Y. | Ann. Date
30-Nov-2024 | 21-Jan-2025
Latest Audited Result
31-May-2024
Announcement Date
30-Sep-2024
Next Audited Result
31-May-2025
Est. Ann. Date
30-Sep-2025
Est. Ann. Due Date
27-Nov-2025
Revenue | NP to SH
167,586.000 | 52,933.000
RPS | P/RPS
3.44 Cent | 9.16
EPS | P/E | EY
1.09 Cent | 28.99 | 3.45%
DPS | DY | Payout %
0.70 Cent | 2.22% | 64.27%
NAPS | P/NAPS
0.04 | 7.89
YoY
null%
NP Margin | ROE
32.26% | 27.23%
F.Y. | Ann. Date
31-May-2024 | 17-Jul-2024
Revenue | NP to SH
172,478.000 | 58,962.000
RPS | P/RPS
3.54 Cent | 8.90
EPS | P/E | EY
1.21 Cent | 26.02 | 3.84%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
2.5% | 16.36%
NP Margin | ROE
35.04% | 30.50%
F.Y. | Ann. Date
30-Nov-2024 | 21-Jan-2025
Hints :
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.
Click the QoQ or YoY on table to view the QoQ or YoY Financial Result page.
Date
Financial Result
Financial Ratio
Per Share Item
Performance
Valuation (End of Quarter)
Valuation (Ann. Date)
| Date | Financial Result | Financial Ratio | Per Share Item | Performance | Valuation (End of Quarter) | Valuation (Ann. Date) | |||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F.Y. | Ann. Date | Quarter | # | Revenue | PBT | NP | NP to SH | Div | Net Worth | Div Payout % | NP Margin | ROE | NOSH | RPS | Adj. RPS | EPS | Adj. EPS | DPS | Adj. DPS | NAPS | Adj. NAPS | QoQ | YoY | EOQ Date | EOQ Price | EOQ P/RPS | EOQ P/EPS | EOQ P/NAPS | EOQ EY | EOQ DY | ANN Date | ANN Price | ANN P/RPS | ANN P/EPS | ANN P/NAPS | ANN EY | ANN DY |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
Discussions
Be the first to like this. Showing 50 of 465 comments
so hard to push up even with those volume, at least alpha is building up the momentum
3 weeks ago
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3514931
I followed Dr. Lee and bought at 33.5 cents
3 weeks ago
only half sen? dream higher la, I wish their business is good so we can get more dividend
2 weeks ago
still havent meet the criteria also, earliest also 2026 only can transfer to main board
2 weeks ago
Dr. Lee bought again. Strong support will be formed at 32 cents
https://klse.i3investor.com/web/insider/detail/D_183655_946568881
1 week ago
Indeed, excellent Q2 performance = good news. Feel free to peruse it 😊
https://klse.i3investor.com/web/blog/detail/NewLifeNewWay/2025-01-22-story-h497934750-Alpha_IVF_Reports_Yet_Another_Record_Q2_FY25_Financial_Results
1 week ago
Alpha IVF Group’s 2QFY5/25 net profit increased 23.6% YoY to RM15.1m thanks to higher sales revenue from foreign patients. Indonesian patients are Alpha IVF’s largest clientele, contributing about 34.9% to its total revenue while patients from China contributed 25.2%. Beyond China, Alpha IVF further expanded in the Southeast Asia region with the establishment of a full-fledged IVF centre in the Philippines and a first satellite clinic in Indonesia, tapping into these rapidly growing markets.
Sadly no dividend announced
1 week ago
Higher sales figures are mostly from foreign patients, good move for Alpha to keep expanding towards China and South East Asia.
1 week ago
Patients dr Indonesia paling byk. Rasa bilangan patient dr Filipina dan Cina juga akan bertmbah scr berdadah pd masa depan
1 week ago
it is undervalued indeed, even analyst forecast that the industry will continue to see decent growth yet the price of the share is not moving at all
1 week ago
The next few quarters should continue to see decent growth, on the back of increased patient volume from China following the launch of the sales representative office
https://www.thestar.com.my/business/business-news/2025/01/23/alpha-ivf-to-see-rising-customer-demand
5 days ago
Alpha said that 2Q25 continued to see a high foreign patient mix, in part due to maiden contribution from the SRO in Shanghai, China. A full quarter’s contribution from the China SRO and the establishment of a satellite clinic in Jakarta, Indonesia should support overall patient volume
5 days ago
even uob still maintaining their buy recommendation, means the current price really below its real value
5 days ago
Short term will get down to 28...it has broken 32 support. No other catalyst until next QR
4 days ago
I dnt think so because there will be another market expansion and it will rebound
1 day ago
Hopefully. Only time will tell. Recent Q earnings did not even move the stock by any means....
1 day ago
Post a Comment
Featured Posts
Latest Videos
MQ Trading Signals
Time
Signal
Duration
Type
2025-01-31 16:50:00
MACD/RSI
10 Mins
SELL
2025-01-31 16:50:00
EMA 5
5 Mins
SELL
2025-01-31 16:50:00
ADX
5 Mins
SELL
2025-01-31 16:45:00
EMA 5
5 Mins
BUY
2025-01-31 16:40:00
ADX
5 Mins
BUY
Apps
Top Articles
1
Dragon Leong blog
2
Stock Market Enthusiast
Feng Shui Market Outlook for FBM KLCI in the Year of the Wood Snake (2025)
3
Stock Market Enthusiast
3 Resilient Stocks That Defied Malaysia’s Market Slump in January 2025 - #GCB, #ABMB, #CDB
4
The Alpha Trader
5
Kenanga Research & Investment
Oil & Gas - Dissecting Petronas and Trump's Impact on the Sector (OVERWEIGHT)
6
Rakuten Trade Research Reports
7
TA Sector Research
8
MQ Market Updates
#
Stock
Score
Daily Stocks
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Stock Name
Last
Change
Volume
Featured Advertisers / Partners
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
ryoyagod
The buying volume is strong, and the momentum is positive. Just wait for the imminent surge!
3 weeks ago